Westwood Holdings Group’s Astrana Health ASTH Stock Holding History

Westwood Holdings Group’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,845	Closed	-$495K	–	485
2022 Q2	$495K	Buy	+12,845	New	+$489K	0.01%	392

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Westwood Holdings Group's ASTH Position: Q3 2022 in Review

Westwood Holdings Group sold out of Astrana Health (ASTH) in Q3 2022, closing a stake of 12,845 shares — an estimated $495K sold.

Westwood Holdings Group first reported a position in ASTH in Q2 2022 and held it in 1 quarter. The position peaked at $495K in Q2 2022. 154 funds tracked by Wall St. Rank hold ASTH as of Q3 2022.

Westwood Holdings Group reported no remaining Astrana Health position as of Q3 2022 after selling out during the quarter.
Westwood Holdings Group sold 12,845 Astrana Health shares in Q3 2022, an estimated $495K.
Westwood Holdings Group first reported a position in Astrana Health in Q2 2022 and held it in 1 quarter.
Westwood Holdings Group's Astrana Health position peaked at $495K in Q2 2022.
154 funds tracked by Wall St. Rank held Astrana Health as of Q3 2022.

Based on Westwood Holdings Group's 13F filing for Q3 2022, filed 14 Nov 2022.